Introduction Executive Summary Hypertriglyceridemia: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Hypertriglyceridemia – DelveInsight’s Analytical Perspective Late Stage Products (Phase III) • Comparative Analysis MND-21: Mochida Pharmaceutical • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis ARO-APOC3: Arrowhead Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis ARGX 116: argenx • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical and Discovery Stage Products • Comparative Analysis VK 1430: Viking Therapeutics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Hypertriglyceridemia Key Companies Hypertriglyceridemia Key Products Hypertriglyceridemia- Unmet Needs Hypertriglyceridemia- Market Drivers and Barriers Hypertriglyceridemia- Future Perspectives and Conclusion Hypertriglyceridemia Analyst Views Hypertriglyceridemia Key Companies Appendix

Table 1 Total Products for Hypertriglyceridemia Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Arrowhead Pharmaceuticals • Mochida Pharmaceutical • Ionis Pharmaceuticals • 89bio • Regeneron Pharmaceuticals • Acasti Pharma Inc. • Staten Biotechnology BV • NorthSea Therapeutics B.V. • Afimmune • Rivus Pharmaceuticals • Novo Nordisk • Viking Therapeutics • Liminal BioSciences • Matinas BioPharma • Arbutus Biopharma • Better Therapeutics